COLUCID PHARMACEUTICALS
CoLucid Pharmaceuticals, Inc., a biotechnology company, focuses on therapies for central nervous system disorders. The company develops COL-144, a neurally acting anti-migraine agent, which is designed to treat migraine; and COL-204, a conjugated stigmine platform that produces novel chemical entities for therapy of sleep/wake disorders, chronic pain, Alzheimer's disease, and psychiatric disorders. CoLucid Pharmaceuticals was founded in 2005 and is based in Research Triangle Park, North Carolina.
COLUCID PHARMACEUTICALS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2005-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.colucid.com
Total Employee:
1+
Status:
Active
Contact:
(919) 649-6184
Email Addresses:
[email protected]
Total Funding:
97.3 M USD
Technology used in webpage:
Font Awesome Amazon Google Maps Google Maps API ASP.NET Amazon Ohio Region Ninja Forms Entrust EV Entrust SSL Omniture SiteCatalyst
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Domain Associates
Domain Associates investment in Series C - CoLucid Pharmaceuticals
TVM Capital Life Science
TVM Capital Life Science investment in Series C - CoLucid Pharmaceuticals
Novo Ventures
Novo Ventures investment in Series C - CoLucid Pharmaceuticals
Care Capital
Care Capital investment in Series C - CoLucid Pharmaceuticals
Auriga Partners
Auriga Partners investment in Series C - CoLucid Pharmaceuticals
Pearl Street Venture Funds
Pearl Street Venture Funds investment in Series C - CoLucid Pharmaceuticals
Pappas Ventures
Pappas Ventures investment in Series C - CoLucid Pharmaceuticals
Triathlon Medical Venture Partners
Triathlon Medical Venture Partners investment in Series C - CoLucid Pharmaceuticals
Domain Associates
Domain Associates investment in Venture Round - CoLucid Pharmaceuticals
Pappas Ventures
Pappas Ventures investment in Venture Round - CoLucid Pharmaceuticals
Official Site Inspections
http://www.colucid.com
- Host name: a4972715dfa2f21c3.awsglobalaccelerator.com
- IP address: 75.2.103.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "CoLucid Pharmaceuticals"
Water Resources Engineering - EcoLucid
EcoLucid provides water resources engineering consulting and advisory services focused on strategy, innovation, and novel solutions to complex challenges.See details»
Who We Are - EcoLucid
We bring our clients over 25 years of deep technical, business, and industry knowledge and experience in civil and water resources engineering coupled with novel solutions to help clients …See details»
EcoLucid - Crunchbase Company Profile & Funding
Where is EcoLucid's headquarters? EcoLucid is located in Boston, Massachusetts, United States. Who are EcoLucid's competitors? Alternatives and possible competitors to EcoLucid may …See details»
colucid.com Company Profile | Management and Employees List
Find contact information for colucid.com. Learn about their Manufacturing market share, competitors, and colucid.com's email format.See details»
ECOLUCID LLC Company Profile | Brookline, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ECOLUCID LLC of Brookline, MA. Get the latest business insights from Dun & Bradstreet.See details»
Marcus Quigley - CEO at EcoLucid | The Org
As CEO of EcoLucid, Marcus drives initiatives at the intersection of technology and environmental practices for diverse clients. Additional roles include serving on the Board of Advisors for the …See details»
EcoLucid - Overview, News & Similar companies | ZoomInfo.com
EcoLucid is a trusted partner to organizations seeking to evolve thoughtfully. We work at the intersection of technology and practice providing services to private and public clients and their …See details»
EcoLucid
Novel Solutions for the Most Complex Environmental and Water ChallengesSee details»
EcoLucid - Contacts, Employees, Board Members, Advisors & Alumni
EcoLucid has 1 current employee profile, Chief Executive Officer, FounderMarcus Quigley.See details»
ECOLUCID LLC - CAGE.report
Organization, Ownership & Certifications Legal Structure: LLC Ownership and Self-Certifications:See details»
Sensoterra Case Studies
By utilizing Sensoterra calibrated for soil moisture data, Ecolucid further analyses this data with weather, rainfall, and other data to offer real-time insights into what’s happening at Green …See details»
CoLucid Pharmaceuticals - Crunchbase Company Profile & Funding
CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.See details»
CoLucid Pharmaceuticals - 2025 Company Profile - Tracxn
Mar 6, 2025 CoLucid Pharmaceuticals - Developer of therapies for central nervous system disorders. Acquired by Lilly. Raised a total funding of $96M over 5 rounds from 10 investors.See details»
Emerging Drug Developer: CoLucid | Fierce Biotech
CoLucid helps define lean and mean in biotech A roster of new biotech companies has sprung up recently that relies on a virtual business model to keep costs down as they advance therapies …See details»
Privacy Policy - EcoLucid
EcoLucid LLC (EcoLucid) is a Massachusetts (US) based limited liability company. This privacy policy will explain how our organization uses the personal data we collect from you when you …See details»
Emerging Drug Developer: CoLucid | Fierce Biotech
Jul 14, 2008 CoLucid A roster of new biotech companies has sprung up recently that relies on a virtual business model to keep costs down as they advance therapies to proof of concept. But …See details»
CoLucid Pharmaceuticals - VentureRadar
"CoLucid was founded by Pappas Ventures and is developing oral Lasmiditan for the acute treatment of migraine headache and intravenous Lasmiditan for treatment of headache pain by …See details»
CoLucid Pharmaceuticals, Inc. | Insights
Eli Lilly & Co. has its second US approval in migraine in a little over one year, as the US Food and Drug Administration okayed Reyvow (lasmiditan) for the acute treatment of migraine on 11 …See details»
QPFs for United States - EcoLucid
Novel Solutions for the Most Complex Environmental and Water ChallengesSee details»
Meet Cotality™: CoreLogic Embraces a New Name and Bold Vision …
22 hours ago CoreLogic today announced its global rebrand to Cotality, marking the company’s progression to a leader in property information, analytics, and data-enabled ...See details»